Denmark vs North Macedonia: The number of people with susceptibility test result for rifampicin
Denmark
113
in 2021
North Macedonia
100
in 2021
Denmark rank
106th
North Macedonia rank
109th
The number of people with susceptibility test result for rifampicin over time
- Denmark
- North Macedonia
How they compare
Denmark currently reports 113 against 100 in North Macedonia, a difference of 13.
That makes Denmark's figure about 1.1 times North Macedonia's.
Across all 5 years both countries report, Denmark has been ahead every year.
Denmark ranks 106th and North Macedonia ranks 109th of 155 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 162 | 130 | 32 | Denmark |
| 2020s | 120.5 | 90.5 | 30 | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or North Macedonia?
- Denmark, at 113 against 100 in North Macedonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and North Macedonia?
- 13, with Denmark ahead.
- How many years of comparable data are there for Denmark and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 106th and North Macedonia ranks 109th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.